C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) C07K 16/18 (2006.01) C07K 16/24 (2006.01) C07K 16/28 (2006.01) C07K 16/46 (2006.01) C07K 19/00 (2006.01) C12N 15/62 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2046904
There are disclosed: a CDR-grafted antibody having at least one chain wherein the framework regions are predominantly derived from a first antibody (acceptor) and at least one CDR is derived from a second antibody (donor), the CDR-grafted antib- ody being capable of binding to the CD4 antigen; processes for its production; nucleotide sequences for use in its production; compositions containing it; and its use in therapy.
Adair John R.
Athwal Diljeet S.
Jolliffe Linda K.
Pulito Virginia L.
Zivin Robert A.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Ortho Pharmaceutical Corporation
LandOfFree
Cd4 specific recombinant antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cd4 specific recombinant antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd4 specific recombinant antibody will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1729383